Research programme: aerosolised ISS - Dynavax

Drug Profile

Research programme: aerosolised ISS - Dynavax

Alternative Names: Aerosolised ISS research programme - Dynavax; Biodefense applications research programme- Dyanvax

Latest Information Update: 16 Apr 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dynavax Technologies
  • Class
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Viral infections

Most Recent Events

  • 16 Apr 2008 Discontinued - Preclinical for Viral infections in USA (Intrapulmonary)
  • 25 Sep 2006 Aerosolised immunostimulatory sequence is still in preclinical trials in the US
  • 12 Nov 2003 Preclinical trials in Viral infections in USA (Intrapulmonary)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top